MedTrace Logo

Variation in Opioid Prescribing and Use for Acute Pain in Diverse Populations

NCT04509115 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1709

Last updated 2023-12-05

No results posted yet for this study

Summary

This study will characterize patient pain and opioid use after an initial opioid prescription for acute pain.

Conditions

  • Opioid Use
  • Opioid Prescribing

Interventions

DRUG

Short-acting opioid prescription for acute pain

Patients not currently using opioids who receive a new short-acting opioid prescription as part of routine care for acute pain will be recruited and followed prospectively for 180 days.

Sponsors & Collaborators

  • Food and Drug Administration (FDA)

    collaborator FED

  • Yale University

    lead OTHER

Principal Investigators

  • Joseph Ross, MD, MHS · Yale University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-11
Primary Completion
2023-11-30
Completion
2023-11-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04509115 on ClinicalTrials.gov